Home › Follicular Lymphoma › Massachusetts › Boston

Pag-aaral pangklinika para sa Follicular Lymphoma sa Boston, MA

Isang pag-aaral para sa Follicular Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Nagre-recruitPhase 3

Tufts Medical Center, Boston
Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07215910

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05006716

Epco, Zanu, Ritux for R/R FL or MZL

Nagre-recruitPhase 2

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06563596

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Nagre-recruitPhase 3

Research Site, Boston
Research Site, Boston

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06549595

NEO100 and High-Grade Meningioma

Nagre-recruitPhase 2

Tufts Medical Center, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05023018

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Nagre-recruitPhase 3

Beth Israel Deaconess Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06091254

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

Epcoritamab and Rituximab for First-line Follicular Lymphoma

Nagre-recruitPhase 2

Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT05783609

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

Nagre-recruitPhase 3

Local Institution - 0145, Boston
Local Institution - 0244, Boston
Local Institution - 0247, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT06911502

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 16, 2026 · NCT06026319

Odronextamab in Low Tumor Volume Advanced FL

Nagre-recruitPhase 2

Beth Israel Deaconess Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT07128641

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

Nagre-recruitPhase 2

Beth Israel Deaconess Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT06510361

Study of SGR-1505 in Mature B-Cell Neoplasms

Nagre-recruitPhase 1

Beth Israel Deaconess Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 30, 2026 · NCT04669171

Emapalumab Prevention of CAR-T Cell Associated Toxicities

Nagre-recruitPhase 2

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT06550141

Pag-aaral para sa Follicular Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.